No IDed (%) | Sensitivity | Specificity | PPV | NPV | LR + | LR- | |
---|---|---|---|---|---|---|---|
Overall | |||||||
SQ + criteria | 366 (45%) | 0.77 (0.71–0.83) | 0.64 (0.60–0.68) | 0.35 (0.30–0.40) | 0.92 (0.89–0.94) | 2.13 (1.87–2.43) | 0.36 (0.27–0.48) |
Criteria only | 218 (27%) | 0.74 (0.68–0.81) | 0.85 (|0.83–0.88)* | 0.56 (0.49–0.63)* | 0.93 (0.91–0.95) | 5.10 (4.15–6.26)* | 0.30 (0.23–0.39) |
HIV-uninfected | |||||||
SQ + criteria | 166 (38%) | 0.68 (0.58–0.79) | 0.69 (0.64–0.73) | 0.31 (0.24–0.38) | 0.31 (0.24–0.38) | 2.18 (1.76–2.71) | 0.46 (0.33–0.64) |
Criteria only | 104 (24%) | 0.71 (0.61–0.81) | 0.86 (0.86–0.83)* | 0.52 (0.42–0.62)* | 0.52 (0.42–0.62)* | 5.17 (3.85–6.95)* | 0.34 (0.24–0.48) |
HIV-infected | |||||||
SQ + criteria | 76 (43%) | 0.74 (0.60–0.88) | 0.66 (0.58–0.74) | 0.37 (0.26–0.48) | 0.90()0.84–0.96) | 2.15 (1.60–2.89) | 0.40 (0.23–0.69) |
Criteria only | 34 (19%) | 0.58 (0.42–0.74) | 0.91 (0.87–0.96)** | 0.65 (0.49–0.81)* | 0.89 (0.84–0.94) | 6.75 (3.69–12.37)* | 0.46 (0.32–0.67) |